Welcome to ERA – Academy of European Law

Objective

This annual conference will provide practitioners with an analysis of the constantly growing measures to promote patient access to information on medicinal products that have been introduced since the review of EU pharmaceutical legislation which entered into force in 2005. The potential offered by social media to exchange information is creating new legal issues which will be explored. This conference will also offer an overview of recent measures adopted at national and EU levels towards access to documents and transparency.

Key topics

• Patient access to digital information: opportunities and risks in the use of social networks
• Legal consequences of the use of social networks by pharmaceutical companies
• Confidential information v right of access
• Trial data and patient confidentiality
• Transparency in EU public procurement procedures
• State of play of the proposal for a new Directive relating to the transparency of measures regulating the pricing of medicinal products for human use (COM (2012) 84 final)
• Upcoming challenges for the pricing of medicinal products
• Strengthening of national rules on transparency in the relationship between pharmaceutical companies and health care professionals
  

Who should attend?

Lawyers in private practice, in-house counsel and other practitioners of law dealing with pharma-ceuticals and medical devices, patents and consumer law.